In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
Publication
, Journal Article
Nanna, MG; Granger, CB
Published in: Ann Intern Med
October 20, 2020
Navarese EP, Khan SU, Kolodziejczak M, et al. Comparative efficacy and safety of oral P2Y 12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials. Circulation. 2020;142:150-60. 32468837.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
October 20, 2020
Volume
173
Issue
8
Start / End Page
JC44
Location
United States
Related Subject Headings
- Ticagrelor
- Randomized Controlled Trials as Topic
- Purinergic P2Y Receptor Antagonists
- Prasugrel Hydrochloride
- Network Meta-Analysis
- Humans
- General & Internal Medicine
- Clopidogrel
- Acute Coronary Syndrome
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Nanna, M. G., & Granger, C. B. (2020). In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel. Ann Intern Med, 173(8), JC44. https://doi.org/10.7326/ACPJ202010200-044
Nanna, Michael G., and Christopher B. Granger. “In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.” Ann Intern Med 173, no. 8 (October 20, 2020): JC44. https://doi.org/10.7326/ACPJ202010200-044.
Nanna MG, Granger CB. In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel. Ann Intern Med. 2020 Oct 20;173(8):JC44.
Nanna, Michael G., and Christopher B. Granger. “In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.” Ann Intern Med, vol. 173, no. 8, Oct. 2020, p. JC44. Pubmed, doi:10.7326/ACPJ202010200-044.
Nanna MG, Granger CB. In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel. Ann Intern Med. 2020 Oct 20;173(8):JC44.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
October 20, 2020
Volume
173
Issue
8
Start / End Page
JC44
Location
United States
Related Subject Headings
- Ticagrelor
- Randomized Controlled Trials as Topic
- Purinergic P2Y Receptor Antagonists
- Prasugrel Hydrochloride
- Network Meta-Analysis
- Humans
- General & Internal Medicine
- Clopidogrel
- Acute Coronary Syndrome
- 3202 Clinical sciences